Clinical trial NCT02399384 - References

Coronary Artery Disease — Pericardial Fat and Inflammation in HIV Patients and Controls

Citation(s)

•   Arai AE
  The cardiac magnetic resonance (CMR) approach to assessing myocardial viability. J Nucl Cardiol. 2011 Dec;18(6):1095-102. doi: 10.1007/s12350-011-9441-5. Review.
•   Burdo TH, Lo J, Abbara S, Wei J, DeLelys ME, Preffer F, Rosenberg ES, Williams KC, Grinspoon S
  Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011 Oct 15;204(8):1227-36. doi: 10.1093/infdis/jir520.
•   Chapon C, Franconi F, Lemaire L, Marescaux L, Legras P, Saint-André JP, Denizot B, Le Jeune JJ
  High field magnetic resonance imaging evaluation of superparamagnetic iron oxide nanoparticles in a permanent rat myocardial infarction. Invest Radiol. 2003 Mar;38(3):141-6.
•   Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG
  Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010 Feb 9;121(5):651-8. doi: 10.1161/CIRCULATIONAHA.109.898585. Epub 2010 Jan 25.
•   Coll B, Parra S, Alonso-Villaverde C, Aragonés G, Montero M, Camps J, Joven J, Masana L
  The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke. 2007 Sep;38(9):2477-84. Epub 2007 Aug 2.
•   de Vos AM, Prokop M, Roos CJ, Meijs MF, van der Schouw YT, Rutten A, Gorter PM, Cramer MJ, Doevendans PA, Rensing BJ, Bartelink ML, Velthuis BK, Mosterd A, Bots ML
  Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J. 2008 Mar;29(6):777-83. Epub 2007 Dec 20.
•   Feldman JG, Goldwasser P, Holman S, DeHovitz J, Minkoff H
  C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):210-4.
•   Fisher SD, Miller TL, Lipshultz SE
  Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis. Atherosclerosis. 2006 Mar;185(1):1-11. Epub 2005 Nov 16. Review.
•   Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis
  Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009 Apr 28;53(17):1475-87. doi: 10.1016/j.jacc.2009.02.007.
•   Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group
  Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS. 2003 May 23;17(8):1179-93.
•   Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S
  Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012 Feb 4;379(9814):453-60. doi: 10.1016/S0140-6736(11)61335-4. Epub 2011 Dec 22.
•   Gronemeyer SA, Steen RG, Kauffman WM, Reddick WE, Glass JO
  Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging. 2000 Sep;18(7):815-8.
•   Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ
  Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004 Feb;147(2):218-23.
•   Haddad F, Hunt SA, Rosenthal DN, Murphy DJ
  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008 Mar 18;117(11):1436-48. doi: 10.1161/CIRCULATIONAHA.107.653576. Review.
•   Hansson GK
  Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. Review.
•   Ho C, Hitchens TK
  A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. Curr Pharm Biotechnol. 2004 Dec;5(6):551-66. Review.
•   Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ
  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008 Nov 4;52(19):1574-80. doi: 10.1016/j.jacc.2008.06.049.
•   Kaplan RC, Kingsley LA, Gange SJ, Benning L, Jacobson LP, Lazar J, Anastos K, Tien PC, Sharrett AR, Hodis HN
  Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS. 2008 Aug 20;22(13):1615-24. doi: 10.1097/QAD.0b013e328300581d.
•   Katsiki N, Mikhailidis DP, Wierzbicki AS
  Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol. 2013 Jul;28(4):458-63. doi: 10.1097/HCO.0b013e3283605fba. Review.
•   Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE
  T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med. 2007 May;57(5):891-7.
•   Kellman P, Arai AE
  Imaging sequences for first pass perfusion --a review. J Cardiovasc Magn Reson. 2007;9(3):525-37. Review.
•   Konishi M, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Matsubara J, Matsuzawa Y, Sumida H, Nagayoshi Y, Nakaura T, Awai K, Yamashita Y, Jinnouchi H, Matsui K, Kimura K, Umemura S, Ogawa H
  Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis. 2010 Apr;209(2):573-8. doi: 10.1016/j.atherosclerosis.2009.10.008. Epub 2009 Oct 12.
•   Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group
  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008 Oct 21;5(10):e203. doi: 10.1371/journal.pmed.0050203.
•   Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, Cotte L, Boccara F, Costagliola D; French Hospital Database on HIV (FHDH)–ANRS CO4
  HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals. Clin Infect Dis. 2012 Aug;55(4):600-7. Epub 2012 May 18.
•   Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ
  C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med. 2006 Jan 9;166(1):64-70.
•   Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis
  Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009 Dec 1;54(23):2129-38. doi: 10.1016/j.jacc.2009.09.009. Review.
•   Lowe GD, Rumley A, McMahon AD, Ford I, O'Reilly DS, Packard CJ; West of Scotland Coronary Prevention Study Group
  Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1529-34. Epub 2004 Jun 17.
•   Lowe GD, Sweetnam PM, Yarnell JW, Rumley A, Rumley C, Bainton D, Ben-Shlomo Y
  C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1957-62. Epub 2004 Aug 12.
•   Machann J, Thamer C, Schnoedt B, Haap M, Haring HU, Claussen CD, Stumvoll M, Fritsche A, Schick F
  Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging. 2005 Apr;21(4):455-62.
•   Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA
  Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis. 2011 Feb;214(2):468-73. doi: 10.1016/j.atherosclerosis.2010.11.013. Epub 2010 Nov 17.
•   Martínez E, Tuset M, Milinkovic A, Miró JM, Gatell JM
  Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy. Antivir Ther. 2004 Oct;9(5):649-63. Review.
•   Nelson AJ, Worthley MI, Psaltis PJ, Carbone A, Dundon BK, Duncan RF, Piantadosi C, Lau DH, Sanders P, Wittert GA, Worthley SG
  Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson. 2009 May 5;11:15. doi: 10.1186/1532-429X-11-15.
•   Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sørensen HT, Gerstoft J
  Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007 Jun 15;44(12):1625-31. Epub 2007 May 10.
•   Oweida AJ, Dunn EA, Foster PJ
  Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide. Mol Imaging. 2004 Apr;3(2):85-95.
•   Park IW, Wang JF, Groopman JE
  HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. Blood. 2001 Jan 15;97(2):352-8.
•   Paton P, Tabib A, Loire R, Tete R
  Coronary artery lesions and human immunodeficiency virus infection. Res Virol. 1993 May-Jun;144(3):225-31.
•   Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel EK; European Society of cardiology; Soceity for Cardiovascular Magnetic Resonance
  Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. J Cardiovasc Magn Reson. 2004;6(4):727-65.
•   Post WS, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, George RT, Brown TT, Jacobson LP
  Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014 Apr 1;160(7):458-67. doi: 10.7326/M13-1754.
•   Raj V, Joshi S, Pennell DJ
  Images in Cardiovascular Medicine. Cardiac magnetic resonance of acute myocarditis in an human immunodeficiency virus patient presenting with acute chest pain syndrome. Circulation. 2010 Jun 29;121(25):2777-9. doi: 10.1161/CIRCULATIONAHA.109.888099.
•   Rajiah P
  Cardiac MRI: Part 2, pericardial diseases. AJR Am J Roentgenol. 2011 Oct;197(4):W621-34. doi: 10.2214/AJR.10.7265. Review.
•   Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M
  MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med. 2003 Aug;50(2):309-14.
•   Restrepo CS, Diethelm L, Lemos JA, Velásquez E, Ovella TA, Martinez S, Carrillo J, Lemos DF
  Cardiovascular complications of human immunodeficiency virus infection. Radiographics. 2006 Jan-Feb;26(1):213-31. Review.
•   Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group
  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
•   Ridker PM, Morrow DA, Rose LM, Rifai N, Cannon CP, Braunwald E
  Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol. 2005 May 17;45(10):1644-8. Epub 2005 Apr 25.
•   Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, Neubauer S, Hahn D
  Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol. 2000;10(3):438-42.
•   Sani MU
  Myocardial disease in human immunodeficiency virus (HIV) infection: a review. Wien Klin Wochenschr. 2008;120(3-4):77-87. doi: 10.1007/s00508-008-0935-3. Review.
•   Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, Dyke CK, Thorgeirsson G, Eiriksdottir G, Launer LJ, Gudnason V, Harris TB, Arai AE
  Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012 Sep 5;308(9):890-6. doi: 10.1001/2012.jama.11089.
•   Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, Aletras AH, Arai AE
  Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging. 2010 Nov;3(6):743-52. doi: 10.1161/CIRCIMAGING.108.835793. Epub 2010 Sep 16.
•   Sosnovik DE, Nahrendorf M, Deliolanis N, Novikov M, Aikawa E, Josephson L, Rosenzweig A, Weissleder R, Ntziachristos V
  Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo. Circulation. 2007 Mar 20;115(11):1384-91. Epub 2007 Mar 5.
•   Tabib A, Greenland T, Mercier I, Loire R, Mornex JF
  Coronary lesions in young HIV-positive subjects at necropsy. Lancet. 1992 Sep 19;340(8821):730.
•   Triant VA, Lee H, Hadigan C, Grinspoon SK
  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12. Epub 2007 Apr 24.
•   Triant VA, Meigs JB, Grinspoon SK
  Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):268-73. doi: 10.1097/QAI.0b013e3181a9992c.
•   Wang YX, Hussain SM, Krestin GP
  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol. 2001;11(11):2319-31. Review.
•   Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R, James OG, Patel MR, Heitner J, Parker M, Velazquez EJ, Steenbergen C, Judd RM, Kim RJ
  Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008 Jul 8;52(2):148-57. doi: 10.1016/j.jacc.2008.03.041.
•   Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J
  Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol. 1989 Jan;152(1):167-73.

Myocardial Adipose Inflammation and Pericardial Adipose Volume as Markers for Coronary Artery Disease In HIV Positive Patients

Details for clinical trial NCT02399384